Sarcopenia and Muscle Aging: A Brief Overview.

Area of Science:

• Gerontology
• Muscle Physiology
• Molecular Biology

Background:

• Global populations are aging, increasing the importance of understanding aging processes.
• Sarcopenia, the age-related loss of skeletal muscle mass and function, is a key geriatric concern and drug development target.

Purpose of the Study:

• To define sarcopenia and review current therapeutic strategies.
• To highlight recent findings on sarcopenia's pathophysiological phenotypes.
• To examine novel therapeutic avenues for sarcopenia.

Main Methods:

• Review of current research on sarcopenia.
• Analysis of findings from mouse models and human samples.
• Examination of pathophysiological phenotypes including muscle fiber types, mitochondrial function, NAD+ metabolism, myokines, and gut microbiota.

Main Results:

• Sarcopenia involves alterations in muscle fiber types, mitochondrial function, NAD+ metabolism, myokines, and gut microbiota in aged muscle.
• Despite research, no universally accepted therapy for sarcopenia currently exists in humans.

Conclusions:

• Understanding sarcopenia's mechanisms is crucial for developing effective treatments.
• Novel therapeutic targets are emerging from ongoing research in aging muscle.
• Further development is needed to create effective therapeutics for maintaining muscle health in aging individuals.